Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), leader mondial des solutions numériques d'investigation et de renseignement basées sur l'IA pour les
New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Built around Cellebrite's industry-leading digital forensics capabilities, C-TEK helps forward-deployed teams quickly triage data from phones, SIM cards, drones and portable media to advance their missions TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 26, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), leader mondial des solutions numériques d'investigation et de renseignement basées sur l'IA pour les
New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Built around Cellebrite's industry-leading digital forensics capabilities, C-TEK helps forward-deployed teams quickly triage data from phones, SIM cards, drones and portable media to advance their missions TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 26, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Bank of America Corp DE lessened its holdings in shares of Cellebrite DI Ltd. (NASDAQ: CLBT) by 11.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 619,699 shares of the company's stock after selling 80,514 shares during the quarter. Bank of America
New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Boston, Massachusetts--(Newsfile Corp. - August 24, 2026) - Block & Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in their Cellebrite DI investment should contact the firm to learn more about how they might recover those losses.
New York, New York--(Newsfile Corp. - August 21, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Cellebrite DI Ltd. (CLBT) Securities Investigation Notice - Levi and Korsinsky PR Newswire NEW YORK, Aug. 20, 2026
Cellebrite DI Ltd. (CLBT) shares sold off after Q2 2026 annual recurring revenue of approximately $507.8 million came in below analyst consensus and the Company's own guidance; Cellebrite lowered its full year outlook in accord; Levi & Korsinsky is investigating.
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten digitalen Ermittlungs- und Aufklärungslösungen für den
New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 19, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite DI Ltd. (CLBT) investors absorbed losses when shares sold off after the Company reported Q2 2026 revenue of roughly $131.1 million and reduced its full-year 2026 ARR and revenue targets -- Levi & Korsinsky is investigating the loss impact to shareholders. Cellebrite DI Ltd. (CLBT) investors absorbed losses when shares sold off after the Company reported Q2 2026 revenue of roughly $131.1 million and reduced its full-year 2026 ARR and revenue targets -- Levi & Korsinsky is investigating the loss impact to shareholders.
New York, New York--(Newsfile Corp. - August 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Boston, Massachusetts--(Newsfile Corp. - August 17, 2026) - Block & Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in their Cellebrite DI investment should contact the firm to learn more about how they might recover those losses.
Shareholders of Cellebrite DI Ltd. (CLBT) took losses when the stock sold off following Q2 2026 revenue of approximately $131.1 million and a reduction in the C
NEW YORK--(BUSINESS WIRE)--Shareholders of Cellebrite DI Ltd. (CLBT) took losses when the stock sold off following Q2 2026 revenue of approximately $131.1 million and a reduction in the Company's full-year 2026 ARR and revenue guidance. If you held CLBT shares and lost money, you have rights and a limited window to assert them -- click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. In a Form 6-K.
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT) shareholders lost money this month after the Company reported second quarter 2026 revenue of approximately
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT) shareholders lost money this month after the Company reported second quarter 2026 revenue of approximately
Cellebrite DI Investigation Notice: Levi and Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT) PR New
Cellebrite DI Ltd. (CLBT) shareholders lost money when the stock sold off more than 30% following the Company's Q2 2026 results -- Levi & Korsinsky is investigating the Company's disclosures concerning their previous projections and related discussions.
New York, New York--(Newsfile Corp. - August 13, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Cellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call Transcript
MILWAUKEE, Aug. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Cellebrite (NASDAQ: CLBT). The investigation results from inaccurate statements Cellebrite may have made regarding its financial statements, business operations and prospects.
Boston, Massachusetts--(Newsfile Corp. - August 13, 2026) - Block & Leviton is investigating Cellebrite DI (NASDAQ: CLBT) for potential securities law violations. Investors who have lost money in their Cellebrite DI investment should contact the firm to learn more about how they might recover those losses.
Cellebrite DI NASDAQ: CLBT reported second-quarter results that fell short of its expectations for annual recurring revenue, citing delayed large transactions, slower-than-anticipated pricing and expansion gains from customer migrations, and added procurement requirements for cloud and artificial intelligence offerings. The company lowered its full-year ARR and revenue outlook while raising its adjusted EBITDA target.
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.12 per share.
Company Reports Second-Quarter 2026 Results ; Company Lowers Full-Year 2026 ARR and Revenue Outlook and Raises Adjusted EBITDA Target TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 13, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Berkshire's operating income jumps 16%, inflation to set the scene for next Fed decision
Ashford Capital Management Inc. lifted its stake in shares of Cellebrite DI Ltd. (NASDAQ: CLBT) by 5.5% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,762,937 shares of the company's stock after buying an additional 92,092 shares during the quarter. Cellebrite
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 21, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 590,777 shares worth $9.25 million.
The partnership unifies what happens in the sky with what's stored on the drone in a single investigative workflow TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 8, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite (CLBT) remains a buy as fundamentals strengthen, with FedRAMP High achieved and federal demand reaccelerating. Q2 ARR guidance of $510–513M implies 22–23% growth, supporting a narrative of renewed momentum post-federal softness. Platform adoption advances, with Inseyets conversions near 60% and growth products now 14% of ARR, lengthening CLBT's growth runway.
Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript
Reduces investigative workloads from weeks to minutes accelerating investigations like never before TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 10, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
Cellebrite Announces Upcoming Investor Events on June 10, 2026 PR Newswire TYSONS CORNER, Va. and PETAH TIKVA, I
Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.
TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
